MX359550B - Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. - Google Patents
Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis.Info
- Publication number
- MX359550B MX359550B MX2015001830A MX2015001830A MX359550B MX 359550 B MX359550 B MX 359550B MX 2015001830 A MX2015001830 A MX 2015001830A MX 2015001830 A MX2015001830 A MX 2015001830A MX 359550 B MX359550 B MX 359550B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- mycobacterium tuberculosis
- antigens
- immunodominant antigens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a las composiciones, dispositivos y métodos contemplados se relacionan a varios antígenos del patógeno M. tuberculosis y su uso en vacunas, agentes terapéuticos, y varias pruebas de diagnóstico. En aspectos particularmente preferidos, los antígenos son inmunodominantes y tienen reactividades cuantificadas y relativas conocidas con respecto a sueros de una población infectada con el patógeno, y/o tienen una asociación conocida con un parámetro de enfermedad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2009/043822 WO2010132054A1 (en) | 2009-05-13 | 2009-05-13 | Compositions and methods for immunodominant antigens of mycobacterium tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX359550B true MX359550B (es) | 2018-10-02 |
Family
ID=41046910
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011012120A MX344052B (es) | 2009-05-13 | 2009-05-13 | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. |
MX2015001830A MX359550B (es) | 2009-05-13 | 2009-05-13 | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011012120A MX344052B (es) | 2009-05-13 | 2009-05-13 | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2429575A1 (es) |
CN (1) | CN102573896B (es) |
MX (2) | MX344052B (es) |
WO (1) | WO2010132054A1 (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20100411A1 (it) * | 2010-07-23 | 2012-01-24 | Massimo Amicosante | Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino. |
CN102899334B (zh) * | 2012-10-29 | 2015-02-25 | 英诺特(唐山)生物技术有限公司 | 一种结核分枝杆菌重组蛋白质及其制备方法 |
CN104419710B (zh) * | 2013-09-04 | 2017-06-16 | 上海市肺科医院 | 一种结核分枝杆菌的耐药新基因及其应用 |
CN103525829B (zh) * | 2013-09-16 | 2016-01-06 | 南京大学(苏州)高新技术研究院 | 一种可用于结核感染诊断的结核分枝杆菌重组抗原的制备 |
CN104805063A (zh) * | 2014-01-24 | 2015-07-29 | 中国人民解放军第三〇九医院 | 结核分枝杆菌潜伏感染相关蛋白及其制备和应用 |
EP3578668B1 (en) | 2014-07-24 | 2020-12-30 | Abbott Molecular Inc. | Methods for the detection and analysis of mycobacterium tuberculosis |
ES2897933T3 (es) * | 2014-08-15 | 2022-03-03 | Oxford Immunotec Ltd | Proteínas de Mycobacterium tuberculosis |
AU2015339452B2 (en) | 2014-10-28 | 2021-01-28 | Wisconsin Alumni Research Foundation | Biomarkers for early diagnosis and differentiation of mycobacterial infection |
WO2017011565A1 (en) | 2015-07-14 | 2017-01-19 | Abbott Molecular Inc. | Compositions and methods for identifying drug resistant tuberculosis |
CN105037561B (zh) * | 2015-08-24 | 2018-07-24 | 华中科技大学 | 一种融合蛋白cmfo及其应用 |
CN105483214A (zh) * | 2015-11-24 | 2016-04-13 | 北京博瑞立安生物技术有限公司 | 一种结核分枝杆菌检测试剂盒及其应用 |
CN105572352B (zh) * | 2016-02-17 | 2017-07-28 | 遵义医学院附属医院 | 一组结核潜伏感染诊断标志物及其用途 |
CN105675863B (zh) * | 2016-02-17 | 2017-10-20 | 遵义医学院附属医院 | 一组耐多药结核病诊断标志物及其用途 |
GB201700555D0 (en) | 2017-01-12 | 2017-03-01 | Peptinnovate Ltd | Method for the treatment of a relapsing-remitting condition |
CN110475863B (zh) * | 2017-01-19 | 2023-10-13 | 株式会社钟化 | 用于检测堪萨斯分枝杆菌的引物组、探针、试剂盒及方法 |
CN108096571B (zh) * | 2017-12-27 | 2021-08-17 | 河南科技大学 | 一种用于防治结核病的结核多肽疫苗及其制备方法、应用 |
WO2020051070A1 (en) * | 2018-09-07 | 2020-03-12 | Wisconsin Alumni Research Foundation | Biomarkers for early diagnosis and differentiation of mycobacterial infection |
CN111948399A (zh) * | 2019-05-16 | 2020-11-17 | 广东体必康生物科技有限公司 | 结核分枝杆菌抗原蛋白Rv1705c及其T细胞表位肽的应用 |
CN110240636A (zh) * | 2019-06-04 | 2019-09-17 | 华中农业大学 | 牛分枝杆菌分子伴侣蛋白GroEL1及其编码基因与应用 |
CN113278633B (zh) * | 2020-02-20 | 2022-10-28 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv基因及编码蛋白和其应用 |
CN113549604A (zh) * | 2020-04-23 | 2021-10-26 | 中国医学科学院病原生物学研究所 | 结核分枝杆菌毒素抗毒素系统Rv1045-Rv1044及其在制备抗结核药物中的应用 |
CN112457410B (zh) * | 2020-11-05 | 2023-04-07 | 迈克生物股份有限公司 | 用于结核分枝杆菌感染检测的抗原组合物 |
CN112481402B (zh) * | 2020-12-29 | 2024-03-22 | 上海国际旅行卫生保健中心(上海海关口岸门诊部) | 一种基于Sanger测序的结核分枝杆菌MLST分型检测用引物组及其应用 |
CN114099659A (zh) * | 2022-01-29 | 2022-03-01 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌Rv0934抗原蛋白、其抗原表位肽及其应用 |
CN114989312B (zh) * | 2022-06-27 | 2023-07-21 | 安徽理工大学 | 一种结核分枝杆菌融合蛋白dr2及其应用 |
CN116120411B (zh) * | 2022-12-07 | 2024-04-12 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌蛋白抗原混合物、多抗原融合蛋白及编码基因和应用 |
CN116063418B (zh) * | 2022-12-08 | 2024-04-12 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌抗原组合物epdpa015及其制备方法与应用 |
CN117186247A (zh) * | 2023-11-07 | 2023-12-08 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌多抗原融合蛋白及编码基因和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294328B1 (en) * | 1998-06-24 | 2001-09-25 | The Institute For Genomic Research | DNA sequences for strain analysis in Mycobacterium tuberculosis |
US6892139B2 (en) * | 1999-01-29 | 2005-05-10 | The Regents Of The University Of California | Determining the functions and interactions of proteins by comparative analysis |
GB0500102D0 (en) * | 2005-01-05 | 2005-02-09 | Isis Innovation | Method for generating a memory t cell response |
EP2368568A1 (en) * | 2006-11-01 | 2011-09-28 | Immport Therapeutics, INC. | Compositions and methods for immunodominant antigens |
GB0716070D0 (en) * | 2007-08-17 | 2007-09-26 | Fusion Antibodies Ltd | Diagnostic method and kit |
-
2009
- 2009-05-13 EP EP09789675A patent/EP2429575A1/en not_active Withdrawn
- 2009-05-13 CN CN200980160460.8A patent/CN102573896B/zh not_active Expired - Fee Related
- 2009-05-13 WO PCT/US2009/043822 patent/WO2010132054A1/en active Application Filing
- 2009-05-13 MX MX2011012120A patent/MX344052B/es active IP Right Grant
- 2009-05-13 MX MX2015001830A patent/MX359550B/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2429575A1 (en) | 2012-03-21 |
CN102573896A (zh) | 2012-07-11 |
CN102573896B (zh) | 2016-05-11 |
MX344052B (es) | 2016-12-02 |
WO2010132054A1 (en) | 2010-11-18 |
MX2011012120A (es) | 2012-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011012120A (es) | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. | |
PH12014501836A1 (en) | Novel adjuvant compositions | |
CA2668100C (en) | Compositions and methods for immunodominant antigens | |
CL2012003299A1 (es) | Vacuna que comprende uno o mas antigenos, uno o mas oligonucleotidos inmunoestimuladores aislados y colesterol; metodo para inducir una respuesta inmune antigeno específica en un sujeto que necesita de la misma. | |
MX2011011505A (es) | Vacuna neumococica y usos de la misma. | |
WO2010037395A3 (en) | Mhc multimers in cancer vaccines and immune monitoring | |
MX343048B (es) | Oligodesoxinucleotidos inmunoestimulantes. | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
MX346596B (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
EA201290956A1 (ru) | Вакцина против вич | |
WO2011007359A3 (en) | Antigen specific multi epitope -based anti-infective vaccines | |
MX2015007753A (es) | Composicion de vacunas para sujetos intactos. | |
NZ630133A (en) | Vaccines for serogroup x meningococcus | |
MX347911B (es) | Vacuna contra virus de diarrea viral de bovinos. | |
BR112012009239A2 (pt) | ''adjuvante para vacinas,vacina, uso do adjuvante, vetores de expressão eucariótica e células eucarióticas modificadas | |
IL219770A (en) | Use of 5l and / or 3l to prepare a drug for use as a vaccine or diagnostic for parasitic disease | |
MX350718B (es) | Vacuna de rinitis equina. | |
WO2011112906A3 (en) | Novel immunogens and methods for discovery and screening thereof | |
PH12014501688A1 (en) | Influenza c virus and vaccine | |
WO2013006401A3 (en) | Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2 | |
WO2012088125A3 (en) | Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis | |
NZ580603A (en) | Intradermal influenza vaccine | |
WO2010006326A3 (en) | Methods and compositions for spore-based vaccines | |
IN2014DN10408A (es) |